ASSOCIATION OF LOW-INCOME SUBSIDY/DUAL ELIGIBILITY AND DISABILITY WITH HIGH-RISK MEDICATION USE AMONG PART D MEDICARE BENEFICIARIES
Author(s)
Chinthammit C1, Bhattacharjee S2, Slack M2, Lo-Ciganic W3, Bentley JP4, Axon D2, Warholak T2
1Eli Lilly and Company, Indianapolis, IN, USA, 2University of Arizona, Tucson, AZ, USA, 3University of Florida,Department of Pharmaceutical Outcomes and Policy, Gainesville, FL, USA, 4University of Mississippi School of Pharmacy, Oxford, MS, USA
OBJECTIVES : Limited evidence exists of the association of low-income subsidy/dual-eligibility status (LIS/DE) and disability with high-risk medication (HRM) use among Medicare Part D beneficiaries with different drug plans. Using the Pharmacy Quality Alliance HRM measure, this study examined the relationship between: 1) LIS/DE and HRM use; and 2) disability and HRM use in Medicare Advantage Prescription Drug Plan (MA-PD) and stand-alone Prescription Drug Plan (PDP) beneficiaries. METHODS : This retrospective cross-sectional study used a 5% national sample of 2013 Medicare administrative claims data to create two groups of beneficiaries aged ≥65 years who were continuously enrolled in a MA-PD or PDP. Beneficiaries with ≥2 prescriptions for the same HRM during 2013 were identified. Multivariable generalized linear mixed models were used to assess the association of: 1) LIS/DE and HRM use; and 2) disability and HRM use, after adjusting for health plan effect and patient-level characteristics in MA-PDs and PDPs. RESULTS : A total of 520,019 MA-PD and 881,264 PDP beneficiaries met the study criteria. Of these, 88,693 MA-PD and 213,096 PDP beneficiaries were LIS/DE, while 48,997 MA-PD and 83,593 PDP were disabled. LIS/DE beneficiaries had a higher proportion of HRM users compared to non-LIS/DE beneficiaries (MA-PD 13.3% versus 9.7%, p<0.001; PDP 17.1% versus 13.2%, p<0.001). Disabled beneficiaries had a higher proportion of HRM users compared to non-disabled beneficiaries (MA-PD 17.0% versus 9.6%, p<0.001; PDP 22.9% versus 13.2%, p<0.001). In multivariable analyses, LIS/DE and disability were associated with HRM use among both MA-PD (LIS/DE odds ratio [OR]=1.07; 95% confidence interval [CI]=1.04-1.10; disability OR=1.38; 95% CI=1.34-1.42) and PDP beneficiaries (LIS/DE OR=1.14; 95% CI=1.12-1.16; disability OR=1.37; 95% CI=1.34-1.40). CONCLUSIONS : LIS/DE and disability were associated with higher HRM use in both MA-PD and PDP beneficiaries, even when controlling for health plans, underscoring the importance of considering these factors when assessing health plan performance on HRM measures.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA
Value in Health, Volume 23, Issue 5, S1 (May 2020)
Code
PNS105
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Quality of Care Measurement
Disease
No Specific Disease